Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Indivior ( (INDV) ) has shared an update.
Barclays PLC has adjusted its voting rights in Indivior PLC, reducing its total voting rights from 7.01% to 6.68%. This change in holdings, notified on July 22, 2025, reflects a strategic shift in Barclays’ investment in Indivior, potentially impacting the company’s shareholder dynamics and market perception.
More about Indivior
Indivior PLC is a UK-based company operating in the pharmaceutical industry, primarily focused on developing and commercializing medications for the treatment of addiction and other serious mental health disorders.
Find detailed analytics on INDV stock on TipRanks’ Stock Analysis page.